RASGRF1 and rheumatoid arthritis: Interestingly, IGF2BP3 improved the stability of Ras protein-specific guanine nucleotide releasing factor 1 (RASGRF1) mRNA to activate the RAS pathway, which activated mTORC1 to promote synovial cell proliferation and inflammatory activation, thereby aggravating joint injury in individuals with RA.